Your Article Summary
Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions
Carcinogenesis, 06/05/09
Moretti D et al. - The observations suggest that calpain 3 variants can play a proapoptotic role in melanoma cells and its downregulation, as observed in highly aggressive lesions, could contribute to melanoma progression.
Related Articles
Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09
Relevance Score: 82%
Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma
Clinics in Dermatology, 11/17/09
Relevance Score: 81%
Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression
Modern Pathology, 11/11/09
Relevance Score: 80%
Tumor Antigen–Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts
Cancer Research, 10/21/09
Relevance Score: 80%
Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial
Clinical Cancer Research, 11/16/09
Relevance Score: 79%
Today in Carcinogenesis...keeping you current
Receive free subspecialty "5-minute updates" via email
Regulating the leukaemia stem cell
Best Practice & Research: Clinical Haematology , 12/09/09
Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways
Endocrine-Related Cancer, 12/08/09
Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
Oncogene, 11/30/09
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Proceedings of the National Academy of Sciences of the United States of America, 12/09/09
Phase II trial of temozolomide and sorafenib in advanced melanoma patients with or without brain metastases
Clinical Cancer Research, 12/09/09
Dynamic Gene Expression Analysis Links Melanocyte Growth Arrest with Nevogenesis
Cancer Research, 12/09/09

See Latest Articles